ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

In Brief: Robert Day New AACI President, John Potter President Elect: Howard Appointment Near

June 21, 1985

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

FDA Designates Zometa For Priority Review.

November 30, 2001

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013